Optimized Clinic Network Recent regulatory changes as a result of the COVID-19 pandemic have resulted in more healthcare services being delivered virtually. Accordingly, and in conjunction with Ketamine One's new telemedicine strategy, many of the clinics acquired by the company are now treating their patients virtually rather than in person at the respective clinic locations. As a result, the Company is accelerating the rebranding and realignment of its portfolio of clinics, with a focus on pioneering mental health care and veteran-centric clinics. The Company's network of clinics currently consists of multiple brands, including IRP Health, Canabo and MindScape, with additional locations and brands to be added both organically and through acquisitions in the near future, including but not limited to the previously announced letters of intent to acquire NY Ketamine Medical Practice PLLC and TriStar Wellness LLC and in partnership with Veteran Services USA. To better serve Ketamine One's mission, the Company has identified certain legacy locations that are well suited for the IRP Health brand and veteran care. After a detailed review of the Company's entire clinic portfolio, including an assessment of each clinic's physical space and lease terms, Ketamine One transitioned several locations to a virtual care model to optimize the clinic portfolio. In summary, Ketamine One currently operates nine clinics treating patients in person, while the remaining former clinic locations continue to treat patients on a virtual basis. The Company is actively seeking new sites well suited to both offer mental health treatments and be used for research by KGK Science, Ketamine One's wholly owned contract research organization. ABOUT iHEALTHOX iHealthOX is a health and wellness benefits company for employers that uses data and advanced technology to turn healthcare spend into high-value investments. With its holistic and proactive approach, iHealthOX uses personalized care plans and online services to reduce absenteeism and increase employee productivity. iHealthOX was founded by CEO Terri Storey, who has 20 years of experience in the Canadian psychiatric and technology sectors, including building one of Ontario's largest mental health treatment organizations and developing the first algorithms that instantly connect the mentally ill with healthcare providers. For more information, please visit www.ihealthox.com. About Ketamine One KetamineOne Capital Limited is a medical hospital consolidation company growing into a leading North American mental health company. It creates critical infrastructure to develop and deliver breakthrough treatments for mental illness. KetamineOne operates a network of clinics in North America and plans to continue to consolidate the highly fragmented industry sector. The recent addition of KGK Science Inc. as the company's contract research arm also makes the company a leader in world-class research thanks to its extensive experience in pharmaceuticals, cannabis and new psychedelic drugs. As a collective company, Ketamine One is committed to meeting the growing demand for safe and accessible treatments for mental illness. On behalf of: KETAMINE ONE Adam DeffettAdam Deffett, Interim CEO For further information contact: Nick Kuzyk, Investor ServicesTel: 1-844-PHONE-K1 (1-844-746-6351)Email: IR@ketamine.one Web: www.ketamine.one Twitter: @KetamineOne Cautionary Statement Regarding Forward-Looking Information: This press release contains forward-looking statements, including but not limited to statements regarding the Company's business, assets or investments, as well as other statements that are not historical facts . Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations on which they are based will materialize. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, thatthat the predictions, forecasts, projections and other forward-looking statements will not materialize. This, in turn, could cause actual performance and results in future periods to differ materially from the estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy generally and the capital markets in particular, investor interest in the business and the future prospects of the company. The forward-looking statements contained in this press release are made as of the date of this press release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. In addition, the Company is under no obligation to comment on the expectations or statements made by any third party with respect to any of the above. The source language (usually English) in which the original text is published is the official, authorized and legal version. This translation is included for better understanding. The German-language version can be shortened or summarized. No responsibility or liability is accepted for the content, correctness, adequacy or accuracy of this translation. From the translator's point of view, the report does not constitute a buy or sell recommendation! Please see the original English notice on www.sedar.com, www.sec.gov, www.asx.com.
Advertisement
Subscribe to more news about the HelloFresh share free of charge
Email address
Please check the email address.
Notifications from ARIVA.DE(By placing your order, you accept the privacy policy)
-1
Note: ARIVA.DE publishes analyses, columns and news from various sources in this section. ARIVA.DE AG is not responsible for content that has been posted by third parties in the "News" area of this website and makes do not own these. This content can be identified in particular by a corresponding "from" label below the article heading and/or by the link "To read the full article, please click here."; The named third party is solely responsible for this content.
